According to Brazilian media Olhar Digital, the Brazilian Health Surveillance Agency (ANVISA) plans to reassess the ban on e-cigarettes. This discussion will include e-cigarettes, pods, and vapes, and the assessment will take place on April 17th (Wednesday).
As early as 2009, e-cigarettes and unheated tobacco have been banned for sale in Brazil. In 2019, ANVISA revisited these products, with the report being delivered by the agency's president Antonio Barra. In December 2023, ANVISA conducted a public consultation to evaluate whether to continue the ban on these products, receiving a total of 13,390 feedback responses.
The department will compile a revised version of the text based on the data collected, expected to be submitted next week. However, the final decision may take longer, as more time may be needed for evaluating the new proposal and accommodating requests for postponement, with some agency members indicating that the original ban may remain in place.
According to last year's public consultation results, 37% of people support the e-cigarette ban, while 59% are against the ban or have reservations about sales of e-cigarettes. Among healthcare professionals, 61% agree with the ban, while 32% hold opposing views.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
